Antineutrophil Cytoplasmic Antibody-associated Vasculitis
📧 Sign up to get email alerts when something new happens for Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis [Phase 3]
This clinical trial update describes a Phase 3 study evaluating salvage therapy for granulomatosis with polyangiitis (ANCA-associated vascul…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) [Phase 1, Phase 2]
This is a clinical trial update for a Phase 1/2 study of NKX019 in immune‑mediated diseases, currently recruiting to assess safety and early…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases [Phase 1]
A Phase 1 exploratory study evaluating the safety and feasibility of YTS109 cell therapy for multiple autoimmune diseases, currently recruit…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Phase 1 clinical study of YTS109 cell therapy for refractory autoimmune diseases is currently recruiting. The trial will evaluate safety and…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase exploratory clinical study evaluating the safety and potential efficacy of an anti-CD19/BCMA U CAR-T cell therapy for relapse…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for CC-97540 in antineutrophil cytoplasmic antibody-associated vasculitis, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) [Phase 1]
Phase 1 clinical trial update for SC291 in severe B-cell–mediated autoimmune diseases; the study is active but not recruiting and includes s…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) [Phase 2]
A Phase 2 clinical trial for NM8074 in antineutrophil cytoplasmic antibody-associated vasculitis is currently not recruiting.